METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), lymphoma is angioimmunoblastic T-cell lymphoma (AITL), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CM...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
12.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), lymphoma is angioimmunoblastic T-cell lymphoma (AITL), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CMML), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics. |
---|---|
Bibliography: | Application Number: US202017435276 |